// App-Quantinova.ai

3972 : Total lesion glycolysis (TLG) as an imaging biomarker of regorafenib treatment in metastatic colorectal cancer (mCRC)

Researchers

Presenter

  • Yoojoo Lim

Principal Investigators

  • Ji-In Bang

  • Sae-Won Han

  • Jin Chul Paeng

  • Jeong Hee Yoon

  • Jeong Min Lee

  • Jae-Kyung Won

  • Gyeong Hoon Kang

  • Seung-Yong Jeong

  • Kyu Joo Park

  • Kyung-Hun Lee

  • Jee Hyun Kim

  • Tae-You Kim

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal Cancer

  • Solid malignancies

Biomarkers

  • Total lesion glycolysis

Drug/Treatment

  • Regorafenib

  • Fludeoxyglucose (18F)

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved